Plné znění - 47/2014 Sb. m. s.

Sdělení o přijetí nového znění Přílohy I (Seznam zakázaných látek a metod - Mezinárodní standard) Mezinárodní úmluvy proti dopingu ve sportu

47/2014 Sb. m. s.

Sdělení

INFORMACE

47

SDĚLENÍ

Ministerstva xxxxxxxxxxxx xxxx,

xxxxxx xx xxxx a xxxxxxxx sdělení Xxxxxxxxxxxx xxxxxxxxxxxx xxxx x. 58/2007 Sb. m. x. x x. 46/2008 Xx. x. x. a nahrazuje xxxxxxx Xxxxxxxxxxxx zahraničních xxxx x. 98/2013 Xx. x. s. x Mezinárodní xxxxxx xxxxx dopingu xx xxxxxx

Xxxxxxxxxxxx xxxxxxxxxxxx xxxx xxxxxxx, xx dne 11. xxxxxxxxx 2013 xxxx generální ředitelkou XXXXXX xxxxxxxx xxxxxxxxx xxxxxx xxxxx Xxxxxxx X - Xxxxxxx xxxxxxxxxx látek x xxxxx - Xxxxxxxxxxx xxxxxxxx Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx.¹⁾

X xxxxx xxxxxx Xxxxxxx X vyslovil xxxxxxx Parlament Xxxxx xxxxxxxxx x xxxxxxxxx xxxxxxxxx xxxxxxxx listinu x xxxxxxx xxxxx Xxxxxxx I Xxxxxx xxxxxxxxxx.

Xxxx xxxxx Xxxxxxx X vstoupilo v xxxxxxxx v xxxxxxx x xxxxxxx 34 xxxx. 3 Úmluvy xxx 1. xxxxx 2014 a xxxxx xxxx xxxxxxxxx x xxxxxxxx x xxx Xxxxxx xxxxxxxxx. Xxxx xxxxxx nového xxxxx Xxxxxxx X x xxxxxxxx xxxxxxxx platit xxxxx Přílohy I Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx sportu xxxxxx xx 1. xxxxx 2013 x xxxxxxxxx pod č. 98/2013 Sb. m. s.

Xxxxxxxx xxxxx Xxxxxxx I x xxxx xxxxxxx xx xxxxxxx xxxxxx xx xxxxxxxxx xxxxxxxx.

¹⁾ Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx xxxxxxx xxx 19. xxxxx 2005 x Xxxxxx xxxx vyhlášena xxx č. 58/2007 Sb. m. s. a č. 46/2008 Sb. m. s.

XXXXXXXXXXX XXXXXX XXXXX XXXXXXX VE XXXXXX
Xxxxxxx X - Xxxxxx xxxxxxxxxx látek x xxxxx - Mezinárodní xxxxxxxx
Xxxxx, 1. xxxxx 2014

XXXXXX ZAKÁZANÝCH XXXXX X METOD DOPINGU XXX XXX 2014

XXXXXXX XXXXXXXXXXXXX XXXXX

Xxxxxx xx 1. ledna 2014

Xxxxx xxxxxx 4.2.2 Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxx všechny Xxxxxxxx xxxxx xxxxx xxxxxxxxxx xx "Xxxxxxxxxx xxxxx" kromě látek xx xxxxxx X1, X2, X4.4, X4.5 x X6(x) x Xxxxxxxxxx xxxxx X1, X2 a X3.

XXXXX X METODY XXXXXXXX XXXXX (XXX SOUTĚŽI X XXXX XXXXXX)

XXXXXXXX LÁTKY

S0. XXXXXXXXXXX LÁTKY

Jakákoliv xxxxxxxxxxxxx xxxxx, xxxxx xxxx xxxxxxxx x xxxxxxxxxxxxx xxxxxxx Xxxxxxx x xxxx aktuálně xxxxxxxxx xxx xxxxxxx terapeutické xxxxxxx jakýmkoliv vládním xxxxxxxxxxxxx regulačním úřadem (xxxx. xxxxxx x xxxxxxxxxxxx xxxx klinickém xxxxxx xxxxxxx xxxx xx ukončené xxxxxxxxxx, xxxxxxxxxx xxxxx, xxxxx xxxxxxxxx xxxxx xxx xxxxxxxxxxx xxxxxxx), xx xxxxxxxx stále.

S1. ANABOLICKÉ XXXXX

Xxxxxxxxxx látky jsou xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX XXXXXXXX (XXX):

(x) Exogenní* XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3x,17β-xxxx); 1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (xxxx-4-xx-3β,17β-xxxx); bolasteron; xxxxxxxx; xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx ([1,2]xxxxxx[4',5':2,3]xxxxxx-4-xx-20-xx-17α-xx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxxx-5α-xxxxxxx-2-xx-17β-xx); drostanolon; xxxxxxxxxxxxx (19-xxx-xxxxxx-4-xx-17α-xx); fluoxymesteron; xxxxxxxxxx; furazabol (17α-methyl[1,2,5]oxadiazolo[3',4':2,3]-5α-androstan-17β-ol); xxxxxxxxx; 4-hydroxytestosteron (4,17β-dihydroxyandrost-4-en-3-on); xxxxxxxxxx; klostebol; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx (17β-xxxxxxx-2α,17α-xxxxxxxx-5α-xxxxxxxxx-3-xx); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxx-4,9-xxxx-3-xx); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxxxx; metribolon (xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxx-4,9,11-xxxxx-3-xx); xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (estr-4-en-3,17-dion); xxxxxxxxxx; norethandrolon; xxxxxxxxxxxx; xxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx (17β-[(xxxxxxxxxxxxxxx-2-xx)xxx]-1'X-xxxxxxxx[3,4,:2,3]-5α-xxxxxxxxxx); xxxxxxxxx; xxxxxxxxxx; stenbolon; 1-xxxxxxxxxxx (17β-xxxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxx (17-xxxxxxx-18α-xxxx-19-xxx-17α-xxxxxx-4,9,11-xxxxx-3-xx); trenbolon (17β-xxxxxxxxxx-4,9,11-xxxxx-3-xx) x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx účinky.

(b) Xxxxxxxxx** XXX, xxxxx jsou xxxxxx xxxxxxxx:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), xxxxxxxxxxxxx (androst-4-en-3,17-dion), dihydrotestosteron, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX), 3β-xxxxxxxxxxxxx-5-xx-17-xx), xxxxxxxxxxx x xxxxxx xxxxxxxxxx x xxxxxxx, ale xx x xxxxxxxx xxxxx xx ně:

5α-androstan-3α,17α-diol	5-androstendion (xxxxxxx-5-xx-3,17-xxxx)
5α-xxxxxxxxx-3α,17β-xxxx	xxx-xxxxxxxxxxxxxxxxxx
5α-xxxxxxxxx-3β,17α-xxxx	xxxxxxxxxxxxxx
5α-xxxxxxxxx-3β,17β-xxxx	xxxxxxxxxxxxxx
xxxxxxx-4-xx-3α,17α-xxxx	3α-xxxxxxx-5αxxxxxxxxx-17-xx
xxxxxxx-4-xx-3α,17β-xxxx	3β-xxxxxxx-5αxxxxxxxxx-17-xx
xxxxxxx-5-xx-3β,17α-xxxx	7α-xxxxxxx-XXXX
xxxxxxx-5-xx-3α,17α-xxxx	7β-xxxxxxx-XXXX
xxxxxxx-5-xx-3α,17β-xxxX	7-xxxx-XXXX
xxxxxxx-5-xx-3β,17α-xxxx	19-xxxxxxxxxxxxxx
4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)	19-xxxxxxxxxxxxxxxxx

Xxx účely xxxxxxx xxxx xxxxx:

* "xxxxxxxx" xx xxxxxxxx x xxxxx, xxxxxx tělo xxxxxxxx xxxxxxxxx xxxxxxxxxxx.

** "xxxxxxxxx " xx xxxxxxxx k xxxxx, xxxxxx xxxx normálně xxxxxxxxx xxxxxxxxx.

2. Xxxxxxx xxxxxxxxxx xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxx modulátory androgenových xxxxxxxxx (XXXX), xxxxxxx, xxxxxxx, zilpaterol, xxx xx x xxxxxxxx xxxxx xx xx.

X2. XXXXXXXXX XXXXXXX, XXXXXXX XXXXXXX X XXXXXXXX XXXXX

Xxxxxxxxxxx látky x xxxxx xxxxx s xxxxxxxx chemickou xxxxxxxxxx xxxx podobnými biologickými xxxxxx jsou xxxxxxxx:

1. Xxxxx xxxxxxxxxxx erytropoesu (xxxx. xxxxxxxxxxxx (XXX), xxxxxxxxxxx (dEPO), stabilizátory xxxxxxx xxxxxxxxxxxxxx xxxxxxx (XXX), methoxypolyethylenglykol-epoetin xxxx (XXXX), xxxxxxxxxxx /Xxxxxxxx/);

2. Xxxxxxxxxxxxxxxxxx (CG) x Xxxxxxxxxxxx xxxxxx (XX) x xxxxxx xxxxxxxxxx xxxxxxx x mužů;

3. Xxxxxxxxxxxxxx a xxxxxx xxxxxxxxxx xxxxxxx;

4. Růstový xxxxxx (XX) x xxxx uvolňující xxxxxxx x xxxxxxxx xxxxxxx xxxxxxx xxxxxx-1 (XXX-1).

Xxxxx xxxx jsou xxxxxxxx xxxxxxxxxxx xxxxxxx faktory:

Fibroblastové xxxxxxx xxxxxxx (XXXx), xxxxxxxxxxxx xxxxxxx faktor (XXX), xxxxxxxxxx xxxxxxx xxxxxxx (MGF), xxxxxxx xxxxxx odvozený x xxxxxxxx xxxxxxxx (PDGF) x vaskulárně-endoteliární xxxxxxx xxxxxx (VEGF), xxxxxx xxxx jakékoliv xxxx xxxxxxx xxxxxxx ovlivňující xxxxxxx xxxx degradaci xxxxxxxx xxxxx, xxxxx x xxxxxx, krevní xxxxxxxx, využití xxxxxxx, xxxxxxxxxxxxx kapacitu xxxx xxxxxxxxxxx xxxx svalových xxxxxx;

x xxxxx látky x xxxxxxxx xxxxxxxxx xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx účinky.

S3. XXXX2- XXXXXXXX

Xxxxxxx xxxx-2 agonisté, xxxxxx všech xxxxxxxxxx xxxxxxxxx isomerů (např. x- x l-), xxxx xxxxxxxx xxxxx xxxxxxxxxxx salbutamolu (maximálně 1600 mikrogramů za 24 xxxxx), xxxxxxxxxxxx xxxxxxxxxxx (maximální podaná xxxxx 54 xxxxxxxxxx xx 24 xxxxx) x xxxxxxxxxxx, pokud xxxx podány v xxxxxxxx x xxxxxxx x xxxxxxxxxxx léčebným xxxxxxx xxxxxxx.

Xxxxxxxxxx salbutamolu x moči v xxxxxxxxxxx vyšší než 1000 xx/xx x xxxxxxxxxx xxxxxxxxxxx x xxxx x koncentraci xxxxx xxx 40 xx/xx nebude považována xx xxxxxxxxx xxxxxxxxxxxx xxxxxxx, xxx xxxx xxxxxxxxxx xx xxxxxxxxx xxxxxxxxxxx nález, pokud xxxxxxxxx xxxxxxxxx kontrolovanou xxxxxxxxxxxxxxxxx studií, xx xxxxxxxxxx xxxxxxxx xxx xxxxxxxx xxxxxxxx terapeutické xxxxxxxxx dávky xxxxx xxx xxxx xxxxxxx xxxxxxx.

X4. XXXXXXXXX X XXXXXXXXXXX MODULÁTORY

Zakázané xx xxxxxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, xxxxxxxxxx:

Xxxxxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxx-1,4,6-xxxxx-3-17-xxxx (xxxxxxxxxxxxxxxxx), 4-xxxxxxxxx-3,6,17-xxxxx (6-xxx), xxxxxxxxx, xxxxxxxxx, xxxxxxxx, xxxxxxxxxxx, ale xx x xxxxxxxx xxxxx xx xx.

2. Xxxxxxxxxx xxxxxxxxxx estrogenových xxxxxxxxx (XXXX), xxxxxxxxxx:

Xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx.

3. Ostatní xxxxxxxxxxxxxx xxxxx xxxxxxxxxx:

Xxxxxxxxxx, xxxxxxxxxxx, xxxxxxxx, ale xx x omezením xxxxx na xx.

4. Xxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, xxx ne x omezením xxxxx xx ně.

5. Metabolické xxxxxxxxxx:

x) Xxxxxxxx;

x) Xxxxxxxx xxxxx xxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxxx /Xxxxxxxxxx Xxxxxxxxxxxx Xxxxxxxxx Xxxxxxxx δ (XXXXδ) agonists/ (xxxx. XX 1516) a Xxxxxxxx xxxxxxxxxxxxxxx xxx xxxxxxxxxx XXX x xxxxxxxxxxx s XXXX xxxxx /XXXXδ-XXX-xxxxxxxxx xxxxxxx xxxxxx (XXXX) xxxx xxxxxxxx/ (např. XXXXX)

X5. XXXXXXXXX A OSTATNÍ XXXXXXXXX LÁTKY

Maskovací látky xxxx zakázané. Xxxxxxxx:

Xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxxxxx (xxxx. xxxxxxxx, nitrožilní podání xxxxxxxx, dextranu, xxxxxxxxxxxxxxxxxx x xxxxxxxxx), xxxxxxxxxx x xxxxx xxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxx. Xxxxxxx xxxxxx xxxxxxxxxxxx xxx xxxxx xxxxxxxx xxxx xxxxxxxx.

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxx, amilorid, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, thiazidy (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), triamteren, vaptany (xxxx. xxxxxxxxx) a xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx biologickými xxxxxx (kromě drospirenonu, xxxxxxxxx a xxxxxxxxx xxxxxx xxxxxxxxxxx x xxxxxxxxxxxx, xxxxx xxxxxx xxxxxxxx).

Xxx xxxxxxx (Xxx Xxxxxxx, případně Xxxx Xxxxxx) xxxxxxxxxxx množství xxxxx xx xxxxxxxxxx xxxxxxxx xxxxxxx (xx. xxxxxxxxxx, xxxxxxxxxx, katin, xxxxxxx, metylefedrin x xxxxxxxxxxxxx) xx xxxxxxx x diuretikem xxxx xxxxx xxxxxxxxx látkou xx xxxxxxxxxx xxxxxxx xxxxxxxxxx Xxxxxxxxxxxx xxxxxxx xx tuto xxxxx xxxxx k té, xxxxx již xxxx xxxxxxx na xxxxxxxxxx xxxx xxxxx xxxxxxxxx xxxxx.

XXXXXXXX XXXXXX

X1. MANIPULACE X XXXX X XXXXXXXX XXXXXXXXXXXX

Xxxxxxxx xx xxxxxxxxxxx:

1. Xxxxxx nebo xxxxxxxxxxxxx xxxxxxxxxxx xxxxxxxx xxxxxxxxx, alogenní (xxxxxxxxx) xxxx xxxxxxxxxxx krve xxxx xxxxxxxxx krvinek x jim podobných xxxxxxxx xxxxxxxxxxx xxxxxx xx xxxxxxxxx systému.

2. Xxxxx zvyšování xxxxxxxx, xxxxxxx nebo dodávky xxxxxxx, zahrnující modifikované xxxxxxxxxxxxx xxxxxxxx (xxxx. xxxxxx náhražky xxxxxxxx xx xxxxxxxxxxx, mikroenkapsulované xxxxxxxxxxx), xxxxxxxxxxxxxxxxxxx a xxxxxxxxxxx (RSR13), ale xx s xxxxxxxx xxxxx xx xx. Xxxxxxxxxxxx xxxxxxxx xxxxxxxx xxxx.

3. Jakákoliv xxxxx xxxxxxxxxxxxxxx manipulace x xxxx xxxx x xxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx xxxx xxxxxxxxxx xxxxxxx.

X2. XXXXXXXX X FYZIKÁLNÍ XXXXXXXXXX

Xxxxxxxx je následující:

1. Xxxxxxxxx, xxxx pokus x xxxxxx, xx xxxxxx xxxxxxx xxxxxxxxx x xxxxxxxx Vzorků xxxxxxxxxx xxx Dopingové xxxxxxxx. To zahrnuje xxxxxx x/xxxx xxxxxx (xxxx. xxxxxxxxxx) moči, xxx ne s xxxxxxxx xxxxx na xx.

2. Xxxxxxxxxx xxxxxx x/xxxx xxxxxxx xxxx xxx 50 ml xx 6 xxxxx xxxxx xxxxxx xxxxxxxxx xxxxxxxxx v průběhu xxxxxxxxxxxx xxxxxxx xxxx xxxxxxxxxx xxxxxxxxxxxxx metod.

M3. XXXXXX XXXXXX

X xxxxxx xxxxxxxxxx xx xxxxxxx xxxxxxxxxxx výkonu je xxxxxxxx xxxxxxxxxxx:

1. Xxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxx analogů;

2. Xxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxxx xxxxx.

XXXXX X XXXXXX ZAKÁZANÉ XXX XXXXXXX

Xxxxx xxxxxxxxx X0 xx X5 x X1 xx X3 xxxxxxxxx výše xxxx Při Xxxxxxx xxxxxxxx x následující xxxxxxx:

XXXXXXXX XXXXX

X6. XXXXXXXXXXX

Xxxxxxx xxxxxxxxxxx xxxxxx xxxxx xxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxx (xxxx. x- x x-) jsou xxxxxxxx, x xxxxxxxx xxxxxxxx xxxxxxxxx v xxxxxxx xxxxxx místního xxxxxxx a xxxxxxxxxxx xxxxxxxxxx do Monitorovacího xxxxxxxx xxx rok 2014*.

Xxxxxxxxxxx zahrnují:

(a) Nespecifická xxxxxxxxxxx:

Xxxxxxxxx, xxxxxxxxxx, amfetamin, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxx, xxxxxxxxxxx, fenproporex, xxxxxxxxx, xxxxxxxxxxxx /4-xxxxxxxxxxxxxx (xxxxxxxx)/, xxxxxxxxxx, xxxxxxxxxxx, xxxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, metamfetamin (d-), xxxxxxxx, modafinil, xxxxxxxxxxxxxx, x-xxxxxxxxxxxxxxx, prenylamin, prolintan.

Stimulancium, xxxxx xxxx xxxxxxxx xxxxxxx x tomto xxxxxxxx, xx Specifickou xxxxxx.

(x) Xxxxxxxxxx stimulancia (xxxxxxxx):

Xxxxxxxxx (xxxxxxxxx)****, benzfetamin, xxxxxxxxxxxxxxxxx, xxxxxxx***, xxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx, famprofazon, xxxxxxxxxxx, fenkamfamin, xxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxx (xxxxxxxxxxxxxxxxxx), xxxxxxxxxxxx, katin**, xxxxxxx x xxxx xxxxxxx (xxxx. mefedron, methedron, xxxx-xxxxxxxxxxxxxxxxxxxxx), levmetamfetamin, meklofenoxát, xxxxxxxxxxxx***, xxxxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxxxx (dimetylpentylamin), níketamid, xxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxx), xxxxxxx, pentetrazol, xxxxxxxxxxxxxx, xxxxxxxxxxxxx*****, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, tenamfetamin (xxxxxxxxxxxxxxxxxxxxx), xxxxxxxxxxxx, tuaminoheptan x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx účinky.

* Následující xxxxx xxxxxxxx do Xxxxxxxxxxxxxx programu 2014 (xxxxxxxxx, fenylefrin, fenylpropanolamin, xxxxxx, nikotin, xxxxxxxxx, xxxxxxxx) nejsou xxxxxxxxxx xx Zakázané látky.

** Xxxxx xx xxxxxxxx xxxxx při xxxxxxxxxxx xxxxx xxx 5 xxxxxxxxxx x 1 xx moči.

*** Efedrin x methylefedrin jsou xxxxxxxx xxx koncentraci xxxxx xxx 10 xxxxxxxxxx x 1 xx xxxx.

**** Xxxxxxx xxxxxx adrenalinu (epinefrinu) (xxxx. nosní, xxxx xxxxxxxx) xxxx xxxx xxxxxx xxxxxxxx x xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxx.

***** Xxxxxxxxxxxxx xx xxxxxxx, pokud xxxx xxxxxxxxxxx x moči xx xxxxx xxx 150 mikrogramů na xxxxxxxx.

X7. XXXXXXXXX

Xxxxxxxx xx xxxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), xxxxxxxx x jeho xxxxxxxx, xxxxxxxxxxx, metadon, xxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx.

X8. XXXXXXXXXXX

Xxxxxxxx (xxxx. xxxxx, xxxxxx x xxxxxxxxx) nebo xxxxxxxxxx xxxxx9-xxxxxxxxxxxxxxxxxxx (XXX) x xxxxxxxxxxxxxx (xxxx. "Xxxxx", XXX018, JWH073 x HU-210) xxxx xxxxxxxx.

X9. GLUKOKORTIKOSTEROIDY

Všechny xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxxxx, rektálně, xxxxxxxxxx nebo xxxxxxxxxxxxx xxxxxxxx jsou zakázané.

LÁTKY XXXXXXXX X XXXXXXXX XXXXXXXX

X1. XXXXXXX

Xxxxxxx (etanol) xx xxxxxxxx xxxxx Xxx Xxxxxxx x xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx bude xxxxxxxx xxxxxxxx xxxxxxxx x/xxxx xxxxxxxx krve. Xxxxxxx xxxxxxx xxx xxxxxxxx xxxxxxxxxxx pravidla je xxxxxxxxxxxx xxxxxxxxxxx alkoholu x xxxx 0.10 x/x.

• Xxxxxxxxxxxx xxxxx (XXX)

• Xxxxxx (XXX)

• Xxxxxxx xxxxxx x xxxxxxxxxxxx (XXX)

• Xxxxxxxxxxx (XX)

• Motocyklový xxxxx (XXX)

• Vodní xxxxxxxxxx (XXX)

X2. XXXX-XXXXXXXXX

Xxxxx xxxx xxxxx xxxxxx, xxxx-xxxxxxxxx xxxx xxxxxxxx xxxxx Xxx Soutěži v xxxxxxxxxxxxx xxxxxxxx.

• Automobilový xxxxx (XXX)

• Xxxxxxxx (xxxxxxx discipliny) (WCBS)

• Xxxx (IGF)

• Lukostřelba (XX) (xxxxxxxx také Xxxx soutěž)

• Xxxxxxxx (XXX) - xxxxx xx xxxxxx x xxxxxxxxxxx xxxxxxxx-xxxxx a X-xxxxx, x xxxxxxxxx X-xxxxx x "xxx xxx"

• Střelba (ISSF, XXX) (xxxxxxxx také Xxxx soutěž)

• Šipky (XXX)

Xxxx-xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxx:

Xxxxxxxxxx, xxxxxxxxxx, atenolol, xxxxxxxxx, bisoprolol, xxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxx, xxxxxxxxxx, labetalol, levobunolol, xxxxxxxxxxxx, xxxxxxxxxx, nadolol, xxxxxxxxxx, pindolol, propranolol, xxxxxxx, timolol, ale xx x omezením xxxxx xx xx.

Informace

Právní xxxxxxx č. 47/2014 Xx. x. x. xxxxx xxxxxxxxx xxxx 20.9.2014.

Právní xxxxxxx x. 47/2014 Xx. x. x. xxx xxxxxx xxxxxxx xxxxxxxxx č. 19/2017 Sb. m. s. x xxxxxxxxx xx 6.4.2017.

Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx změna xxxxx uvedeného právního xxxxxxxx.